NICE Talks

We're joined by health visitor Karen McLean and health psychologist Vivien Swanson, two members of the guideline committee, to discuss the changes made to the updated guideline to support nutrition and weight management in pregnancy, and nutrition in children up to 5 years. Find the guideline here: www.nice.org.uk/guidance/NG247

In this episode we're going to be learning more about NICE's guidance for robotic assisted surgery. Our guests are Dr Anastasia Chalkidou, NICE's HealthTech programme director. And John McGrath, consultant urologist at North Bristol NHS Trust, and chair of the NHSE Steering Committee for Robotic Assisted Surgery. Learn more about NICE's guidance for: Robotic-assisted surgery for soft tissue procedures: https://www.nice.org.uk/guidance/HTE21 Robotic-assisted surgery for orthopaedic procedures: https://www.nice.org.uk/guidance/HTE22

To mark endometriosis awareness month this March we discuss the global initiative, Endometriosis Explained, aiming to educate and support those affected by this condition. In this episode, we're joined by Emma Cox, CEO of Endometriosis UK and gynaecologist Christian Becker from the University of Oxford. Find our guideline here: https://www.nice.org.uk/guidance/ng73 And our quality standard here: https://www.nice.org.uk/guidance/qs172

In this episode we're going to be learning about how NICE is preparing to use artificial intelligence. Dr Pall Jonnson, programme director for data and real-world evidence at NICE and Dr Stephen Duffield, associate director for real-world evidence at NICE discuss the impact of this dynamic and rapidly advancing field. Find out more about NICE's work in AI and watch our recent webinar at: https://www.nice.org.uk/about/what-we-do/digital-health/artificial-intelligence-at-nice

We're joined by Jules Fielder, who was diagnosed with stage 4 lung cancer in 2021, Dr Jesme Fox, medical director of the Roy Castle Lung Cancer Foundation, Dr Tom Newsom-Davis, consultant medical oncologist at Chelsea and Westminster Hospital, and Chair-Elect of the British Thoracic Oncology Group, and Dr Lynn Campbell, consultant medical oncologist at Belfast City Hospital and committee member for the NICE lung cancer guidelines.

In this episode we discuss our consultation on NICE's routing criteria for highly specialised technologies. Professor Jonathan Benger, our deputy chief executive and chief medical officer, outlines the proposals. Visit the consultation page to have your say: https://www.nice.org.uk/guidance/indevelopment/GID-PMG10008/consultation/html-content The consultation is open from Thursday 19 December 2024 and will run until Thursday 30 January 2025.

In this episode we're going to be learning about the updated NICE guideline on the identification and management of the menopause. Our guests are Marie Anne Ledingham, a Consultant Clinical Adviser at NICE and an NHS obstetrician and gynecologist. And Professor Martha Hickey, consultant in Gynaecology at the Royal Women's Hospital, Victoria, Australia and topic advisor on the NICE guideline committee. Learn more about the guideline here: And the discussion aid here:

In this episode we're going to be learning about the role of NICE's independent advisory committees. How they operate, who are the members and what flexibility they have in deciding what medicines should be made available to NHS patients in England. Our guests are NICE's director of medicines evaluation Helen Knight and Professor Steve O'Brien, one of our independent advisory committee chairman.

In this episode, we hear from Professor Jonathan Benger, NICE's deputy chief executive and interim director of our Centre for Guidelines. He's joined by Dr Bryony Kendall who is a GP and sits on NICE committees producing guidelines on women's health. They discuss the vital role of our independent advisory committees and how you can get involved. Find out more about joining a NICE committee: www.nice.org.uk/get-involved/our-committees

The National Institute for Health and Care Excellence has, for the first time, published a guideline on the identification and management of adrenal insufficiency, a rare condition which occurs when the adrenal glands do not produce enough essential hormones – particularly cortisol and aldosterone. We're joined by Dr Helen Simpson, a consultant endocrinologist at UCLH NHS Foundation Trust and Sally Tollerfield an endocrine clinical nurse specialist at Great Ormond Street Hospital, to discuss the guideline and the benefits it will provide to patients and healthcare professionals.

We're joined by Mark Chapman, director of NICE's HealthTech programme and Verena Stocker, director of Innovation, Research, Life Sciences and Strategy at NHS England to discuss the benefits and opportunities the proposed pathway will offer. Take part in the consultation: https://www.engage.england.nhs.uk/specialised-commissioning/building-an-integrated-rules-based-medtech-pathway/

In this episode, our guests reflect on 25 years of NICE, how the organisation has developed, the impact its had and how it will change to adapt to the challenges of the next 25 years. Guests: NICE CEO Dr Sam Roberts, Chief Medical Officer for England Professor Sir Chris Whitty, MHRA CEO Dame June Raine, Director of Value and Access at Association of British HealthTech Industries Luella Trickett, and Director of the Bennett Institute for Applied Data Science Ben Goldacre.

Following the publication of our new guideline, ovarian cancer: identifying and managing familial and genetic risk, the latest episode of NICETalks focuses on genetic testing and how it can help to identify those most at risk of ovarian cancer. We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen Mary University of London and Barts Health NHS Trust, Dr Judith Hayward, GP with special interest in genetics and Joanne Stanford who joined us to share her personal experience of genetic testing.

In this month's podcast, we speak with Jeanette Kusel, director of NICE Advice and Luella Trickett, director of value and access at the Association of British HealthTech Industries. They outline the benefits and opportunities NICE Advice can provide. Go to: https://www.nice.org.uk/about/what-we-do/life-sciences/nice-advice-service?utm_medium=podcast&utm_source=nicetalks&utm_campaign=january2024&utm_term=landingpage&utm_content=linkclick

In this episode, the directors of NICE's guidance producing centres reflect on the highlights of 2023. We hear from Mark Chapman, interim director of HealthTech; Helen Knight, director of medicines evaluation; and Professor Jonathan Benger, chief medical officer and interim director of the centre for guidelines.

More than 10,000 virtual ward beds will be used by the NHS in England this winter to care for people with an acute respiratory infections. To learn more about the benefits and opportunities of introducing a virtual ward, or hospital at home service, our guests are Mark Salmon, programme director in the Science, Evidence, and Analytics Directorate at NICE and Becky Housley, consultant nurse at Hampshire Hospitals NHS Foundation Trust, with responsibility for the virtual health hub.

It is estimated that there are around 85,000 strokes every year in England, with over 1 million people currently living with its long-term effects. We catch up with Jon Brown, chair of the independent committee and Professor Stephen Hill, lay member on the committee about NICE's updated guidance on stroke rehabilitation.

We're proposing changes to how we select topics for guidance production. This is to ensure we focus on what matters most to the health and care system. In this month's podcast, we hear from Professor Jonathan Benger, NICE's chief medical officer, and Dr Jeanette Dickson, chair of council at the Academy of Medical Royal Colleges, about how this will work.

We're making some changes to how we evaluate medicines to help get new treatments to patients quicker. In this month's podcast, we hear from Jenniffer Prescott, programme director within NICE's Centre for Health Technology Evaluation and Victoria Jordan from The Association of the British Pharmaceutical Industry about our new approach.

On 10 July NHS England published proposals for establishing an antimicrobial products subscription model for products that offer exceptional value to patients and the NHS. This builds on a recent pilot project that we co-led which paid companies a fixed annual fee for antimicrobials based on their value to the NHS, rather than the volume used. We speak with Sophie Cooper, NICE's senior scientific adviser, and David Glover, NHS England's assistant director of medicines analysis.

We speak with Meindert Boysen, NICE's head of international affairs, and Dr Nicole Mittmann, vice president of scientific evidence, methodologies and resources at CADTH - Canada's drug and health technology agency. They discuss the global partnerships that are enabling NICE to remain at the forefront of guidance development methodology.

Following Mental Health Awareness Week, we hear about 4 NICE-approved digital technologies that can help children and young people with mild to moderate symptoms of anxiety or low mood. Our guests are Sarah Byron, NICE's programme director for devices, diagnostics and digital, and Lily Tang, deputy director of digital investment strategy at NHS England.

As part of Bowel Cancer Awareness Month, we chat with 2 members of our colorectal cancer guideline committee. We're joined by Justin Davies, a consultant colorectal surgeon, and Julie Hepburn, a patient who has had colorectal cancer. They discuss the warning signs and symptoms, available treatments and their involvement in guideline development.

Chief executive Dr Sam Roberts outlines her priorities for NICE by National Institute of Health and Care Excellence (NICE)

In this episode we discuss urinary tract infections (UTI's) and the publication of NICE' new quality standard. The guests are: Dr Tessa Lewis, a GP and specialist committee member on NICE's independent quality standards committee, and we speak to a patient about their experiences of dealing with recurrent UTIs in their early adulthood to find out what challenges they faced.

In this episode we discuss the role NICE plays in patient safety. The guests are: Professor Kevin Harris, senior responsible office for patient safety at NICE, and clinical advisor to the Interventional Procedures Programme and Professor Jane Blazeby, Professor of Surgery at University of Bristol.

Reducing health inequalities is part of NICE's DNA. We offer evidence-based recommendations to help improve the health of communities. The equitable implementation of NICE recommendations ensures that care provided is effective, makes efficient use of resources and reduces inequalities and unwarranted variation. Taking part in this episode is NICE chief executive Dr Sam Roberts; was Dr Bola Owolabi, direcor of healthcare inequalities at NHS England; Dr Lesley Owen, a technical advisor at NICE; and Dr Aoife Molloy, a senior clinical advisor at the National Inequalities Improvement programme at NHS England. Learn more about NICE's role in reducing health inequalities at: https://www.nice.org.uk/about/what-we-do/nice-and-health-inequalities

We speak to Consultant Respiratory Physician Dr Hitasha Rupani, Medicines Consultant Clinical Adviser at NICE Jonathan Underhill and asthma patient Sheba Joseph about NICE's recently published patient decision aid on asthma inhalers and climate change. The aid supports people with asthma to consider whether they might be able to use inhalers which have a smaller carbon footprint as part of their treatment plan. You can view the patient decision aid by visiting the NICE website: https://bit.ly/3fnLt1K

In September 2022, NICE published its guideline on the assessment, management and preventing recurrence of self-harm. We speak to Professor Nav Kapur who was the topic expert on the committee. He outlines what the recommendations say and how people who self-harm can best be supported.

In this month's NICE Talks podcast we speak to Dr Gail Allsopp, interim medical director at NICE, and Richard Jackson, patient advocate who was diagnosed with melanoma, a form of skin cancer, in 2006. We hear from Richard about his personal experience and Dr Gail Allsopp talks us through some of the current NICE recommended treatments, as well as what people can do to protect themselves from increased risk.

On this month's podcast we find out more about the launch of NICE's early value assessment programme in medical technology. This pilot will look at least 10 medical technologies, of which at least six will be digital health technologies, and provide quicker assessments of early value to identify the most promising technologies that can be used in the NHS. Our guests are Mark Chapman, NICE's interim director of Medical Technology, and Andrew Davies, digital health lead at the ABHI.

This month's NICE Talks podcast focusses on NICE's new guideline on social work with adults experiencing complex needs. We chat with Rebecca Harrington, who chaired the NICE committee which developed the guideline, Bryn Lloyd-Evans, an associate professor working in the division of psychiatry at UCL, and Ellie, a service user who was a lay member of the NICE guideline committee, about the positive impact the recommendations will have for people using social work services.

In May 2022, NICE published medical technologies guidance on Sleepio to treat insomnia. It is the first digital therapeutic for treating insomnia recommended by NICE. In this episode we'll learn more about the technology and the process NICE went through to evaluate it. Our guests are Anastasia Chalkidou, associate director of the Medical technologies evaluation programme at NICE. And Professor Colin Epsie, founder and chief scientist at Big Health, the company behind Sleepio.

In her first interview with NICE Talks, chief executive Sam Roberts gives her initial thoughts of the organisation, her plans for the next 12 months and outlines how she plans to tackle some of the challenges. She reflects on how NICE will adapt to new drugs, digital technologies, devices and diagnostics and explains how she plans to build upon the solid foundations established by her predecessors.

In this episode we talk about NICE's recently published guideline on integrated health and social care services for people experiencing homelessness. The guideline was developed in partnership with the Centre for Homelessness Impact and the Office for Health Improvement and Disparities. The guideline outlines how people experiencing homelessness can access services tailored for their needs. It highlights that more effort and targeted approaches are often needed to ensure that people experiencing homelessness have access to the same standard of health and social care as the general population. We spoke to Guillermo Rodriguez-Guzman, Head of Evidence and Data at the Centre for Homelessness Impact and Rachel Johns, deputy regional director at the Office for Health Improvement and Disparities and Chair of the NICE guideline committee on homelessness.

In this episode we're going to be talking about NICE's evidence standards framework for digital health technologies. Working alongside system partners, we've produced the framework for the developers and adopters of digital health technologies. It provides them with the information to ensure new technologies are clinically effective and offer economic value. We'll be talking to Mark Salmon, a programme director in the Science, Evidence and Analytics directorate at NICE. And by Andrew Davies, the Digital Health Lead at the Association of British HealthTech Industries.

In this episode, we speak with Helen Knight, programme director in NICE's Centre for Health Technology Evaluation, and Dr Jane Adam, chair of one of our independent appraisal committees. They discuss what our changes mean for patients, the NHS and industry.

In this episode of our NICE Talks podcast, we speak with Professor Gillian Leng, our chief executive, and Dr Mark Kroese, chair of our diagnostics advisory committee. They reflect on the past year and look forward to 2022.

In this month's podcast, we discuss how we worked with stakeholders at the start of the pandemic to produce evidence-based rapid guidelines for COVID-19. We chat with Fiona Glen, NICE's programme director in centre for guidelines and David Chandler, chief executive of the Psoriasis and Psoriatic Arthritis Alliance (PAPAA). They talk about ensuring the guidelines were informed by the best quality evidence and real-world data but also not adversely influenced by during the infodemic.

In this month's podcast, we discuss our health technology evaluation methods, processes and topic selection consultation. We chat with NICE's deputy chief executive and director of the Centre for Health Technology Evaluation, Meindert Boysen, and Victoria Barrett from The Association of the British Pharmaceutical Industry. They talk about what the proposals mean for patients, the NHS and industry, and whether they go far enough.

In our monthly podcast we discuss with Prof Gillian Leng, NICE chief executive, and Marie Burnham, guideline committee chair, why shared decision making is such a vital part of healthcare and the work that went into developing such an important guideline.

NICE's recent recommendations in its guideline on the assessment and management of chronic pain have generated a lot of debate. In this episode, we talk with two member of the committee who developed the guideline recommendations. They are Cathy Stannard, a pain consultant in Gloucestershire and who was the clinical lead on the NICE chronic pain guideline committee. And Colin Wilkinson, who was a lay member on the guideline committee.

This month we discuss why everyone with an interest in what NICE does should take part in the process review consultation. We're joined by Jennifer Prescott, programme director in the centre for health technology evaluation at NICE and Eric Low, of Eric Low Consulting and the former chief executive of Myeloma UK. You can take part in the consultation at: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/reviewing-our-process-for-health-technology-evaluation--consultation

Each NICE committee contains at least two patient or patient group representatives. In this episode we find out how NICE's Public Involvement Programme works with these lay members to support their work with NICE and discover what it's like to be a patient representative on a committee. Joining host Matthew Brown are Laura Norburn, senior operations manager for NICE's Public Involvement Programme and Jo Jerrome, chief executive of Thrombosis UK.

How are NICE and the government working to ensure digital health technologies reach NHS patients? We speak with Lord James Bethell of Romford, the Department of Health and Social Care's minister for innovation and Meindert Boysen, NICE deputy chief executive and director of the centre for health technology evaluation.

As 2020 comes to a close, we're taking a look back at our biggest challenges and achievements this year, and what we're most looking forward to in the years ahead. In this episode we speak with Professor Gillian Leng, our chief executive, and our new chairman, Sharmila Nebhrajani, OBE, as they reflect on 2020 and look forward to the years ahead.

In this episode of NICE Talks, we look at substance abuse and addiction. What can we do to prevent it, and how can we treat addiction? We speak to Professor Jim McCambridge, professor of addictive behaviours and public health at the University of York, and Dr Tim Leighton, director of professional education and research at Action on Addiction. See our guidance on substance misuse here: https://www.nice.org.uk/guidance/ng64

This is a special edition of the NICE Talks podcast to celebrate the inaugural World Evidence-Based Healthcare (EBHC) Day on Tuesday 20 October 2020. NICE is an official partner for World EBHC Day and the theme of this year's event is ‘from evidence to impact'. Dr Adriana Robayo from the Colombia Instituto de Evaluacion de Tecnologias en Salud (Institute of Health Technology Assessment) joins our host – NICE International's Pilar Pinilla-Dominguez – to discuss the challenges in adopting an evidence-based approach to improving health outcomes. To find out more about World Evidence-Based Healthcare Day visit https://worldebhcday.org/

2020 has been designated by the World Health Organisation as the Year of the Nurse and Midwife. Nursing and midwifery impact us all at some point in our lives and this year is a great opportunity to celebrate their work. We speak to Zeenath Uddin, Head of Quality and Safety at the Royal College of Midwifery, and Leanne Howlett, Service User Chair of Coventry and Warwickshire MVP, about the role of midwives in maternity care.

In this month's podcast we'll be looking at whether a long term chronic condition such as type 1 diabetes should prevent regular exercise. We speak with Chris Bright, a Welsh International Futsal player, who has lived with type 1 diabetes for 20 years; Professor Partha Kar a Consultant Endocrinologist at Portsmouth Hospitals NHS Trust and a National Specialty Advisor, Diabetes, for NHS England; and chiropractor Peter Dixon, President of the Royal College of Chiropractors and NICE Fellow. In this podcast we discuss the NICE recommendations on physical activity for those with type 1 diabetes - https://www.nice.org.uk/guidance/ng17/chapter/1-Recommendations#physical-activity

In this month's podcast we'll be looking at the influenza virus. How can we increase uptake of the flu jab? Why is it important to spread awareness of the flu and the ways you can protect yourself? We speak with Dr Nisha Jayatilleke, national speciality advisor for immunisations at NHS England and NHS improvement, as well as Jess Eagelton, policy officer at the British Lung Foundation. Also featuring in this podcast is Patricia Campbell, flu lead and support to occupational health at St George's Hospital NHS FT. In this podcast we discuss the NICE guidelines on increasing flu uptake - https://www.nice.org.uk/guidance/ng103